Switch to:

Biomarin Pharmaceutical EV-to-EBITDA

: 5,883.11 (As of Today)
View and export this data going back to 1999. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Biomarin Pharmaceutical's enterprise value is $14,367 Mil. Biomarin Pharmaceutical's EBITDA for the trailing twelve months (TTM) ended in Sep. 2019 was $2 Mil. Therefore, Biomarin Pharmaceutical's EV-to-EBITDA for today is 5,883.11.

NAS:BMRN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -26007   Max: 6199.4
Current: 5883.09

-26007
6199.4

During the past 13 years, the highest EV-to-EBITDA of Biomarin Pharmaceutical was 6199.40. The lowest was -26007.00. And the median was -79.75.

NAS:BMRN's EV-to-EBITDA is ranked lower than
100% of the 291 Companies
in the Biotechnology industry.

( Industry Median: 18.36 vs. NAS:BMRN: 5883.09 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2019-12-09), Biomarin Pharmaceutical's stock price is $79.39. Biomarin Pharmaceutical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.26. Therefore, Biomarin Pharmaceutical's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Biomarin Pharmaceutical EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Biomarin Pharmaceutical Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -302.37 -252.59 -19.99 169.37 -2,130.07

Biomarin Pharmaceutical Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.34 -2,130.07 -1,111.64 -587.94 5,011.50

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Biomarin Pharmaceutical EV-to-EBITDA Distribution

* The bar in red indicates where Biomarin Pharmaceutical's EV-to-EBITDA falls into.



Biomarin Pharmaceutical EV-to-EBITDA Calculation

Biomarin Pharmaceutical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=14366.564/2.442
=5,883.11

Biomarin Pharmaceutical's current Enterprise Value is $14,367 Mil.
Biomarin Pharmaceutical's EBITDA for the trailing twelve months (TTM) ended in Sep. 2019 was -11.441 (Dec. 2018 ) + -23.803 (Mar. 2019 ) + -9.151 (Jun. 2019 ) + 46.837 (Sep. 2019 ) = $2 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Biomarin Pharmaceutical  (NAS:BMRN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Biomarin Pharmaceutical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=79.39/-0.26
=

Biomarin Pharmaceutical's share price for today is $79.39.
Biomarin Pharmaceutical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was -0.03 (Dec. 2018 ) + -0.32 (Mar. 2019 ) + -0.21 (Jun. 2019 ) + 0.3 (Sep. 2019 ) = $-0.26.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Biomarin Pharmaceutical EV-to-EBITDA Related Terms


Biomarin Pharmaceutical EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)